Author | Lois Wingerson


Palliative Care Doctors Find Meaning in Death; Oncologists Find Distress

March 31, 2011

An ethnographic study of palliative care specialists reveals that many of them find dealing with dying patients a gratifying experience. The scant evidence about oncologists on this subject paints a much different picture.

Marking a New Pathway for Hormone-Resistant Breast Cancer Treatment

March 16, 2011

P13K inhibitors, now in the earliest stages of clinical testing, receive hopeful attention as an alternative for patients with aromatase inhibitor resistance. A new study proposes how they should be used, and for whom.

With New Melanoma Drug, Clinical Trials System Shows Its Age

February 17, 2011

Patients with advanced melanoma now have access to the BRAF inhibitor PLX4032, which has shown survival advantages in a Phase III trial, as long as they have the "right" mutation. The drug's history so far is proving a case study on the challenges of developing personalized cancer treatment.